Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Pharmaceutical Drugs Global Market Report 2018 - Metabolic Disorders Drugs Expected to Grow at a CAGR of 9% During 2017-2021 -

Research and Markets
Posted on: 20 Mar 18

The "Pharmaceutical Drugs Global Market Report 2018" report has been added to's offering.

The increasing shift from prescription to non-prescription drugs, growing development of personalized medicine and moving away from animal testing methods are some of the major trends in the pharmaceutical industry. There has been an increasing push towards the development of personalized medicine. Personalized medicine is also referred to as precision medicine, the idea of which is to provide medical care according to patient's individual characteristics, needs, preferences and genetic makeup. According to a survey by the Tufts Center, 94% of pharmaceutical companies have invested in personal medicine research. For instance, Roche through its drug and diagnostics approach to cancer, HER2-positive therapies generated about $20 billion in sales.

Musculoskeletal Disorders Drugs was the largest segment in the global pharmaceutical drugs market in 2017, accounting for about 14% of the market. Metabolic Disorders Drugs had the highest CAGR of 11.6% during 2013-2017; this segment is expected to grow at a CAGR of 9% during 2017-2021. Other segments covered in the report include cardiovascular drugs, oncology drugs, anti-infective drugs, central nervous system drugs, genito-urinary drugs, respiratory diseases drugs, gastrointestinal drugs, hematoloty drugs, dermatology drugs, ophthalmology drugs.

The North America pharmaceutical drugs market is worth $341.1 billion, and is the largest in the world. It currently has about 36.5% share of the global pharmaceutical drugs market. This was mainly due to the presence of major pharmaceutical companies, increasing patent expirations and improved access to affordable healthcare in the region. The pharmaceutical drugs market in Asia-Pacific is the second largest in the world; it currently has about 21.5% of the global pharmaceutical drugs market.

The market for pharmaceutical drugs is highly competitive. Novartis AG was the largest player with 4.5% share in the global pharmaceutical drugs market in 2017, followed by Sanofi S.A., F. Hoffman-La Roche Ltd., Pfizer Inc. and Gilead Sciences Inc.


  • Markets covered: Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs.
  • Time series: Five years historic and forecast.
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Companies Mentioned

  • F. Hoffman-La Roche Ltd.
  • Gilead Sciences Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

For more information about this report visit

View source version on

Business Wire

Last updated on: 20/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.